What is the current market price range of pomalidomide?

Pomalidomide is an immunomodulator that is mainly used to treat patients with multiple myeloma (Multiple Myeloma), especially those who have developed resistance to or relapsed with first-line drugs such as Lenalidomide and Bortezomib. Such patients usually have received multiple treatment options and have complex conditions, so the introduction of pomalidomide is of great significance in improving survival and quality of life. Currently, the drug has been widely included in the treatment guidelines of many countries around the world and is considered one of the key drugs in the treatment of advanced multiple myeloma.

In terms of indications, pomalidomide is mainly used in combination with dexamethasone for adult patients with multiple myeloma who have received at least two previous treatment regimens. Especially when the patient is resistant to both lenalidomide and a proteasome inhibitor, the efficacy is more clear.

In terms of market price, pomalidomide, as an original drug, has been launched in the Chinese market and entered the national medical insurance catalog. Although the price has dropped after being included in medical insurance, the price is still relatively high because it is a targeted therapy drug. Taking 15 capsules as an example, the market price of a box may be between 10,000 and 20,000 yuan. After medical insurance reimbursement, depending on regional policies, the patient's out-of-pocket cost may still be around several thousand yuan. It is recommended that patients learn the latest specific prices and reimbursement ratios through the hospital pharmacy or medical insurance window before taking medication.

For patients with heavy financial burdens, there are currently some cost-effective alternative versions on the market, mainly from generic drug manufacturers in India, Laos and other countries. Among them, the generic version of pomalidomide produced by Lucius Pharmaceutical Factory in Laos is relatively common. Its active ingredients are consistent with the original drug. The price on some third-party drug purchasing platforms ranges from about 300 to 500 yuan. Of course, this is also affected by exchange rate fluctuations and import and export channels.

Reference materials:https://en.wikipedia.org/wiki/Pomalidomide